Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracycline in Epidermolysis Bullosa
NCT00336154Phase 4Withdrawn
- Sponsor
- Rambam Health Care Campus
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of tetracycline in epidermolysis bullosa (EB) (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Number of blisters. Status: withdrawn.
02
Drugs
tetracycline
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on NCT00336154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336154.